Sinofy company information, Employees & Contact Information

Rare Blood Disorders Sanofi

Sanofi Rings the Closing Bell Nasdaq

Why Sanofi's R&D chief is 'pretty pragmatic' about a 'mixed' year of clinical development Fierce Biotech

Sanofi hops on the US investment bandwagon with $20B commitment through 2030 Fierce Pharma

Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study BioSpace

Patient Engagement: Informing & Empowering Patients Sanofi

Sanofi sues HHS to defend 340B rebate policy Healthcare Dive

Thermo Fisher bolsters US fill-finish capacity with Sanofi plant purchase Fierce Pharma

Sanofi pens $395M China pact for Arrowhead metabolic med awaiting approval decision Fierce Biotech

Digital Transformation and Artificial Intelligence Sanofi

With FDA nod, Sanofi's Wayrilz becomes 1st US BTK drug approved for immune thrombocytopenia Fierce Pharma

Sustainability: Building a Healthier World Sanofi

Sanofi spices up Type 1 diabetes awareness with sponsorship of new UK girl group Fierce Pharma

Environmental Impact and Healthcare Systems’ Resilience Sanofi

Global Health Unit: Expanding Healthcare Access Sanofi

Sanofi charts biggest China investment to date with plans for €1B insulin 'manufacturing base' in Beijing Fierce Pharma

Our Responsible Business Values & Ethics Sanofi

Sustainable and Equitable Access to Healthcare Sanofi

A New Era of Biopharma Production with AI Sanofi

Digital and AI Powered Manufacturing & Supply: Delivering Faster and Safer for Patients Sanofi

Our Global Manufacturing & Supply Network Sanofi

CEO of pharma giant Sanofi says businesses should stop ‘AI washing’ Fortune

Sanofi commits ‘at least $20bn’ to US manufacturing through 2030 Pharmaceutical Technology

Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race Sanofi

Our Science Sanofi

Sanofi becomes latest pharma to hold fire on UK R&D investments as funding fallout continues Fierce Biotech

A Legacy of Impact Sanofi

Sanofi sheds $13 billion in value on weak trial results for eczema drug Reuters

Sanofi to buy US biopharma group Blueprint for up to $9.5 billion Reuters

Sanofi's German, French premises hit by EU probe amid vaccines market abuse concerns Fierce Pharma

Sanofi Fattens Venture Unit With $625M Infusion for Rare Disease, Neuro Innovation BioSpace

Sanofi exploring vaccine production in Vietnam with local partner Reuters

Sanofi's $110M radioligand therapy hits response rate goal in phase 2 tumor trial Fierce Biotech

Sanofi phase 3 eczema win falls short of analyst expectations Fierce Biotech

With Opella proceeds burning a hole in its pocket, Sanofi snaps up Blueprint for $9.1B Fierce Pharma

Sanofi Makes $1.6B Vaccine Bet With Vicebio Acquisition BioSpace

Sanofi's troubled MS hopeful tolebrutinib hit by FDA delay Fierce Biotech

Sanofi Hops Aboard US Manufacturing Blitz With $20B Commitment BioSpace

Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor in new indication Fierce Biotech

Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals Fierce Pharma

Sanofi pens $1.8B research deal for 2 bispecific antibodies aimed at autoimmune, immunology Fierce Biotech

Sanofi to acquire Vigil Neuroscience in $470 million deal to boost neurological pipeline Reuters

Sanofi hands back cancer NK cell engager to Innate amid autoimmune pivot Fierce Biotech

Sanofi and Regeneron's high-flying Dupixent on course for an 'inflection year' in COPD Fierce Pharma

Sanofi Confident Tariffs Will Have Limited Impact on Finances in 2025 BioSpace

Sanofi signs up Chrissy Teigen for diabetes screening campaign Fierce Pharma

Sanofi to invest $437 mln in India global centre, double its workforce Reuters

Sanofi Rings the Opening Bell Nasdaq

Sanofi market value tanks following weak results on eczema drug trials Fast Company

In latest AI Play, Sanofi Bets $630M+ for Formation Bio’s JAK/SYK Blocker BioSpace

Sanofi in 'exclusive negotiations' to sell 50% stake in €16B consumer health unit Opella Fierce Pharma

Sanofi pays SK bioscience €50M as children's pneumococcal vaccine enters phase 3 Fierce Biotech

Sanofi returns to Orano with €300M for radioligand 'pioneer' project Fierce Biotech

Paris 2024 Partnership Sanofi

Sanofi begins 'full pipeline reprioritization' with layoffs in tow, R&D chief tells staff Fierce Biotech

Sanofi, Formation and OpenAI design AI tool to slash clinical trial timelines Fierce Biotech

Sanofi keeps Novavax afloat with $1.2B bet on its vaccine platform Fierce Pharma

Sanofi lifts 2024 profit forecast on strength in Dupixent, new products Reuters

Sanofi uses the industrial metaverse to revolutionize training and operational efficiency Microsoft

Skyhawk Announces Collaboration Agreement with Sanofi for Oncology and Immunology Targets PR Newswire

Sanofi shakes up leadership as specialty care head Bill Sibold departs to pursue outside opportunity Fierce Pharma

Sanofi-Genzyme: Still successful 5 years after the acquisition? Labiotech.eu

Sanofi to cut US price of its most-prescribed insulin by 78% Reuters

Sanofi pumps $750M into VC unit to push deeper into biotech investing Fierce Biotech

Sanofi started—and lost—$28B bidding war for Horizon. Is the company's M&A appetite still rumbling? Fierce Pharma

Sanofi FutureBrand

Sanofi plans to unload a $13B Regeneron stake. Is a rare disease buyout next? Fierce Pharma

Sanofi breaks into digital therapeutics with mental health app for MS patients Fierce Pharma